PATRICIA BAXTER to Cyclin-Dependent Kinase 4
This is a "connection" page, showing publications PATRICIA BAXTER has written about Cyclin-Dependent Kinase 4.
Connection Strength
0.045
-
A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042). Pediatr Blood Cancer. 2021 04; 68(4):e28879.
Score: 0.045